Neurofibromatoses - 25 Studies Found
Active, not recruiting |
: Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas :
|
Recruiting |
: Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma : Neurofibromatosis Type 1 : 2015-10-20 :
|
Recruiting |
: Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients : Neurofibromatosis Type 1 : 2010-10-08 |
Recruiting |
: Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1 : Neurofibromatosis Type 1 : 2016-05-25 :
|
Completed |
: Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas : Neurofibromatosis : 2012-08-22 : Drug: Gleevec Gleevec® will be dosed orally 440 mg/m^2/day (max 800 mg/day) for pediatric subjects |